202 related articles for article (PubMed ID: 22652876)
1. Particle shape effects in vitro and in vivo.
Harris BJ; Dalhaimer P
Front Biosci (Schol Ed); 2012 Jun; 4(4):1344-53. PubMed ID: 22652876
[TBL] [Abstract][Full Text] [Related]
2. Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.
Caldorera-Moore M; Guimard N; Shi L; Roy K
Expert Opin Drug Deliv; 2010 Apr; 7(4):479-95. PubMed ID: 20331355
[TBL] [Abstract][Full Text] [Related]
3. Non-spherical micro- and nanoparticles: fabrication, characterization and drug delivery applications.
Mathaes R; Winter G; Besheer A; Engert J
Expert Opin Drug Deliv; 2015 Mar; 12(3):481-92. PubMed ID: 25327886
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers for oral drug delivery.
Zhang L; Wang S; Zhang M; Sun J
J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles in drug delivery: past, present and future.
Couvreur P
Adv Drug Deliv Rev; 2013 Jan; 65(1):21-3. PubMed ID: 22580334
[TBL] [Abstract][Full Text] [Related]
6. Targeting of injectable drug nanocrystals.
Fuhrmann K; Gauthier MA; Leroux JC
Mol Pharm; 2014 Jun; 11(6):1762-71. PubMed ID: 24766270
[TBL] [Abstract][Full Text] [Related]
7. In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration.
Singh G; Pai RS
J Pharm Pharmacol; 2014 Aug; 66(8):1062-76. PubMed ID: 24779896
[TBL] [Abstract][Full Text] [Related]
8. Historical Perspective of Clinical Nano and Microparticle Formulations for Delivery of Therapeutics.
Batty CJ; Bachelder EM; Ainslie KM
Trends Mol Med; 2021 Jun; 27(6):516-519. PubMed ID: 33903019
[TBL] [Abstract][Full Text] [Related]
9. Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles.
Morachis JM; Mahmoud EA; Almutairi A
Pharmacol Rev; 2012 Jul; 64(3):505-19. PubMed ID: 22544864
[TBL] [Abstract][Full Text] [Related]
10. The effect of particle shape on cellular interaction and drug delivery applications of micro- and nanoparticles.
Jindal AB
Int J Pharm; 2017 Oct; 532(1):450-465. PubMed ID: 28917985
[TBL] [Abstract][Full Text] [Related]
11. Liposomal drug delivery systems: from concept to clinical applications.
Allen TM; Cullis PR
Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
[TBL] [Abstract][Full Text] [Related]
12. Top-down particle fabrication: control of size and shape for diagnostic imaging and drug delivery.
Canelas DA; Herlihy KP; DeSimone JM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):391-404. PubMed ID: 20049805
[TBL] [Abstract][Full Text] [Related]
13. Mold-templated inorganic-organic hybrid supraparticles for codelivery of drugs.
Maina JW; Cui J; Björnmalm M; Wise AK; Shepherd RK; Caruso F
Biomacromolecules; 2014 Nov; 15(11):4146-51. PubMed ID: 25321318
[TBL] [Abstract][Full Text] [Related]
14. Functionalized gold nanoparticles for drug delivery.
Han G; Ghosh P; Rotello VM
Nanomedicine (Lond); 2007 Feb; 2(1):113-23. PubMed ID: 17716197
[TBL] [Abstract][Full Text] [Related]
15. Suprachoroidal drug delivery to the back of the eye using hollow microneedles.
Patel SR; Lin AS; Edelhauser HF; Prausnitz MR
Pharm Res; 2011 Jan; 28(1):166-76. PubMed ID: 20857178
[TBL] [Abstract][Full Text] [Related]
16. Particle engineering for pulmonary drug delivery.
Chow AH; Tong HH; Chattopadhyay P; Shekunov BY
Pharm Res; 2007 Mar; 24(3):411-37. PubMed ID: 17245651
[TBL] [Abstract][Full Text] [Related]
17. Oral delivery of poorly soluble compounds by supersaturated systems.
Lee TW; Boersen NA; Hui HW; Kurtulik P
Ther Deliv; 2011 Jun; 2(6):685-90. PubMed ID: 22822502
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles in drug delivery and environmental exposure: same size, same risks?
Borm PJ; Müller-Schulte D
Nanomedicine (Lond); 2006 Aug; 1(2):235-49. PubMed ID: 17716113
[TBL] [Abstract][Full Text] [Related]
19. Controlling drug nanoparticle formation by rapid precipitation.
D'Addio SM; Prud'homme RK
Adv Drug Deliv Rev; 2011 May; 63(6):417-26. PubMed ID: 21565233
[TBL] [Abstract][Full Text] [Related]
20. Drug-loaded nanocarriers: passive targeting and crossing of biological barriers.
Rabanel JM; Aoun V; Elkin I; Mokhtar M; Hildgen P
Curr Med Chem; 2012; 19(19):3070-102. PubMed ID: 22612696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
